• 제목/요약/키워드: Biopharmaceuticals

검색결과 56건 처리시간 0.027초

Construction of Novel Bifunctional Chimeric Proteins Possessing Antitumor and Thrombolytic Activities

  • Hui, Jing;Dai, Youjin;Bian, Yuanyuan;Li, Hui;Cui, Xiaojin;Yu, Xiaojie;You, Song;Hu, Fengqing
    • Journal of Microbiology and Biotechnology
    • /
    • 제22권7호
    • /
    • pp.894-901
    • /
    • 2012
  • Based on their respective antitumor and thrombolytic activities, the superantigen staphylococcal enterotoxin C2 (SEC2) and staphylokinase (Sak) were chosen for the construction of the novel chimeric proteins Sak-linker-SEC2 and SEC2-linker-Sak using a linker composed of nine Ala residues. Both chimeric proteins possessed nearly the same PBMC proliferation stimulating activity and antitumor activity as SEC2 and thrombolytic activity as Sak. Neither the SEC2 or Sak component of each chimeric protein affected the activity of the other component. The results presented in this study provide a possible strategy to prevent and cure tumor thrombus.

Acaricidal Components of Medicinal Plant Oils Against Dermatophagoides farinae and Dermatophagoides pteronyssinus

  • Cho, Jang-Hee;Sung, Bo-Kyung;Lim, Mi-Youn;Kim, Hyeon-Jin;Lee, Sang-Guei;Lee, Hoi-Seon
    • Journal of Microbiology and Biotechnology
    • /
    • 제14권3호
    • /
    • pp.631-634
    • /
    • 2004
  • The oils of Acorus gramineus, Cinnamomum sieboldii, Eugenia aromatica, and Inula helenium were tested for their acaricidal activity against Dermatophagoides farinae and D. pteronyssinus. Responses varied according to dose and mite species. As compared to the oils, the oil most toxic to D. farinae and D. pteronyssinus was E. aromatica, followed by C. sieboldii, A. gramineus, and I. helenium. On the basis of $LD_{50}$ values of the oils in A. gramineus, C. sieboldii, and E. aromatica, the compound most toxic against D. farinae and D. pteronyssinus was eugenol congeners (isoeugenol>eugenol>acetyleugenol) followed by benzyl benzoate, salicylaldehyde, safro1, DEET, cinnamyl alcohol, and 3-carene. As a naturally occurring acaricide, these oils and eugenol congeners could be useful as new acaricidal agents against Dermatophagoides spp.

Body Weight Changes of Laboratory Animals during Transportation

  • Lee, Sung-Hak;Nam, Hyun-Sik;Kim, Jin-Sung;Cho, Hye-Jung;Jang, Yu-Mi;Lee, Eun-Jung;Choi, Eun-Sung;Jin, Dong-Il;Moon, Hong-Sik
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제25권2호
    • /
    • pp.286-290
    • /
    • 2012
  • The majority of laboratory animals were transported from commercial breeders to a research facility by ground transportation. During the transportation, many biological functions and systems can be affected by stress. In this experiment, the change of body weight during the transportation was measured and the recovery periods from the transportation stress established based on the body weight changes. Total 676 laboratory animals which were aged between 3 to 9 wk old were studied. The transportation time taken from container packing to unpacking the container was approximately 24 h. The temperature of animal container was constantly maintained by air-conditioning and heating equipment. Rats were found to be more sensitive than mice. The body weight of rats was significantly decreased 3.71% (p<0.05) compared to the body weight of mice which decreased 0.9% There was no significant difference between the strains in the same species. When the changes of body weights were compared between delivery days, C57BL/6 mice showed the most variable changes compared to other species and strains. Consequently, C57BL/6 was more sensitive to stress than the other strains and the transportation process needs to be standardized to reduce between day variability. To establish the recovery periods from transportation stress, the body weight changes were measured during the acclimation period. Although the body weight of animals decreased during transportation, animals recovered their weight loss after the next day.

Improvement of Natamycin Production by Cholesterol Oxidase Overexpression in Streptomyces gilvosporeus

  • Wang, Miao;Wang, Shaohua;Zong, Gongli;Hou, Zhongwen;Liu, Fei;Liao, D. Joshua;Zhu, Xiqiang
    • Journal of Microbiology and Biotechnology
    • /
    • 제26권2호
    • /
    • pp.241-247
    • /
    • 2016
  • Natamycin is a widely used antifungal antibiotic. For natamycin biosynthesis, the gene pimE encodes cholesterol oxidase, which acts as a signalling protein. To confirm the positive effect of the gene pimE on natamycin biosynthesis, an additional copy of the gene pimE was inserted into the genome of Streptomyces gilvosporeus 712 under the control of the ermE* promoter (permE*) using intergeneric conjugation. Overexpression of the target protein engendered 72% and 81% increases in the natamycin production and cell productivity, respectively, compared with the control strain. Further improvement in the antibiotic production was achieved in a 1 L fermenter to 7.0 g/l, which was a 153% improvement after 120 h cultivation. Exconjugants highly expressing pimE and pimM were constructed to investigate the effects of both genes on the increase of natamycin production. However, the co-effect of pimE and pimM did not enhance the antibiotic production obviously, compared with the exconjugants highly expressing pimE only. These results suggest not only a new application of cholesterol oxidase but also a useful strategy to genetically engineer natamycin production.

세포배양 유래 생물의약품 제조공정에서 Reovirus, Bovine Viral Diarrhea Virus, Bovine Parainfluenza Virus 동시 검출을 위한 Multiplex Reverse Transcription-PCR (Multiplex Reverse Transcription-PCR for Simultaneous Detection of Reovirus, Bovine Viral Diarrhea Virus, and Bovine Parainfluenza Virus during the Manufacture of Cell Culture-derived Biopharmaceuticals)

  • 오선환;배정은;김인섭
    • 한국미생물·생명공학회지
    • /
    • 제40권4호
    • /
    • pp.339-347
    • /
    • 2012
  • 동물세포배양 유래 생물의약품 생산 공정에서 다양한 외래성 바이러스가 오염된 사례가 있기 때문에 바이러스 안전성 보증을 위한 바이러스 검출시험이 필수적이다. Reovirus (Reo), bovine viral diarrhea virus (BVDV), bovine parainfluenza virus (BPIV)는 동물 세포주와 동물 세포 배양 공정에 오염되는 대표적인 RNA 바이러스이다. 세포배양 유래 생물의약품의 안전성을 확보하기 위해, 세포주, 원료물질, 제조공정, 완제품에서 Reo, BVDV, BPIV를 동시에 검출할 수 있는 Multiplex Reverse Transcription (RT)-PCR 시험법을 확립하였다. Reo, BVDV, BPIV에 특이적인 primer를 선별하였으며, multiplex RT-PCR 시험법을 최적화하였다. Reo, BVDV, BPIV를 동시에 검출할 수 있는 multiplex RT-PCR 시험법의 민감도는 각각 $7.76{\times}10^2\;TCID_{50}/ml$, $7.44{\times}10^1\;TCID_{50}/ml$, $6.75{\times}10^1\;TCID_{50}/ml$이었다. 확립된 multiplex RT-PCR을 생물의약품 제조공정 검증에 적용할 수 있는지 확인하기 위하여 인위적으로 각 바이러스를 오염시킨 CHO 세포에서 검출 시험을 실시한 결과 각 바이러스를 감염시킨 CHO 세포와 세포배양 상청액에서 각 바이러스를 검출할 수 있었다. 위와 같은 결과에서 확립된 multiplex RT-PCR시험법은 세포주, 원료물질, 제조공정, 완제품에서 Reo, BVDV, BPIV를 동시에 검출할 수 있는 특이성과 민감성이 우수한 시험법임을 확인하였다.

Improving Patient Compliance with Biopharmaceuticals by Reducing Injection-Associated Pain

  • So, Jineon
    • Journal of mucopolysaccharidosis and rare diseases
    • /
    • 제1권1호
    • /
    • pp.15-18
    • /
    • 2015
  • Biopharmaceuticals, with their ability to treat many unmet needs, are seen as promising medications in diabetes mellitus, growth hormone deficiency, chronic renal failure, cancer, and rheumatoid arthritis. However, almost all biopharmaceuticals should be administrated by injection; IV, IM, and SC. In addition, these treatments are long term, and patients should receive frequent injections for many years. Patient compliance is therefore of critical importance to ensure treatment benefits. Therefore, the goal of drug product development should be focused on improving patient compliance by reducing injection-associated pain as well as stable formulation development. This review will suggest the kinds of factors that should be considered to minimize injection pain with regard to formulation, device, and injection procedures focused on SC injections.

생물의약품 제조 공정에서 Porcine transmissible gastroenteritis virus 정량 검출을 위한 TaqMan Probe Real-Time RT-PCR 개발 (Development of TaqMan Probe Real-Time RT-PCR for Quantitative Detection of Porcine Transmissible Gastroenteritis Virus During the Manufacture of Biopharmaceuticals)

  • 이재일;한상은;김인섭
    • 한국미생물·생명공학회지
    • /
    • 제43권3호
    • /
    • pp.267-274
    • /
    • 2015
  • 세포주를 이용하여 생산하는 생물의약품과 생산용 세포주는 세포 배양 과정 중에 사용되는 돼지 유래 trypsin으로 부터 외래성 돼지 유래 바이러스가 오염될 가능성이 있다. PTGV는 세포배양 유래 생물의악품 제조공정에서 오염될 수 있는 외래성 바이러스 중의 하나이다. 본 연구에서는 생물의 약품 제조공정에서 PTGV 안전성을 확보하기 위해, 세포주, 원료물질, 제조공정, 완제품에서 PTGV를 정량적으로 검출하고, 제조공정에서 PTGV 제거 검증을 위한 시험법으로 활용이 가능한 TaqMan probe real-time RT-PCR 시험법을 확립하였다. PTGV에 특이적인 primer와 probe를 선별하여 PTGV 정량검출 시험법을 최적화하였다. 세포배양법에 의한 감염역가와 비교한 결과 real-time RT-PCR의 검출한계는 1.10 × 100 TCID50/ml이었다. 확립된 시험법의 신뢰성을 보증하기 위해 시험법 검증을 실시한 결과 특이성과 재현성, 완건성이 우수함을 확인하였다. 확립된 real-time RT-PCR 을 생물의약품 제조공정 검증에 적용할 수 있는지 확인하기 위하여 인위적으로 PTGV를 오염시킨 CHO-K1 세포주에서 PTGV 검출 시험을 실시하였다. PTGV를 감염시킨 CHO-K1 세포에서 세포변병효과를 관찰할 수 없었지만, 세포배양액에서 PTGV를 정량적으로 검출할 수 있었다.

바이오의약품의 단백질 분리 및 정제를 위한 Avantor® ACE® 와이드 포어 HPLC 컬럼 가이드 (Avantor® ACE® Wide Pore HPLC Columns for the Separation and Purification of Proteins in Biopharmaceuticals)

  • Matt James;Mark Fever;Tony Edge
    • FOCUS: LIFE SCIENCE
    • /
    • 제1호
    • /
    • pp.3.1-3.7
    • /
    • 2024
  • The article discusses the critical role of chromatography in the analysis and purification of proteins in biopharmaceuticals, emphasizing the importance of comprehensive characterization for ensuring their safety and efficacy. It highlights the use of Avantor® ACE® HPLC columns for the separation and purification of proteins, focusing on the analysis of intact proteins using reversed-phase liquid chromatography (RPLC) with fully porous particles. This article also details the application of different mobile phase additives, such as TFA and formic acid, and emphasizes the advantages of using type B ultra-pure silica-based columns for efficiency and peak shape in biomolecule analysis. Additionally, it addresses the challenges of analyzing intact proteins due to slow molecular diffusion and introduces the concept of solid-core (or superficially porous) particles, emphasizing their benefits over traditional porous particles for the analysis of therapeutic proteins. Furthermore, it discusses the development of Avantor® ACE® UltraCore BIO columns, specifically designed for the high-efficiency separation of large biomolecules, such as proteins, and demonstrates their effectiveness in achieving high-resolution separations, even for higher molecular weight proteins like monoclonal antibodies (mAbs). In addition, it underscores the complexity of analyzing and characterizing intact protein biopharmaceuticals, requiring a range of analytical techniques and the use of wide-pore stationary phases, operated at elevated temperatures and with relatively shallow gradients. It highlights the comprehensive range of options offered by Avantor® ACE® wide pore columns, including both fully porous and solid-core particles, bonded with a variety of complementary stationary phase chemistries to optimize selectivity during method development. The use of ultrapure and highly inert base silica is emphasized for enabling the use of lower concentrations of mobile phase modifiers without compromising analyte peak shape, particularly beneficial for LC-MS applications. Then the article concludes by emphasizing the significance of reversed-phase liquid chromatography and its compatibility with mass spectrometry as a valuable tool for the separation and analysis of intact proteins and their closely related variants in biopharmaceuticals.

  • PDF

연속 유동 Ultraviolet-C 반응기(UVivatec)의 바이러스 불활화 효과 평가 (Evaluation of Viral Inactivation Efficacy of a Continuous Flow Ultraviolet-C Reactor (UVivatec))

  • 배정은;정은교;이재일;이정임;김인섭;김종수
    • 한국미생물·생명공학회지
    • /
    • 제37권4호
    • /
    • pp.377-382
    • /
    • 2009
  • 사람과 동물 유래의 혈장, 세포, 조직 등을 이용하여 생물의약품을 생산하기 위해서는 바이러스 안전성 확보가 필수적이다. 바이러스 안전성 보증을 위해 생물의약품 제조공정은 바이러스 불활화/제거 단계를 포함하여야 한다. 짧은 파장자외선(UVC) 조사는 바이러스 불활화 효과가 매우 높은 것으로 알려졌지만, UVC 조사로 인한 단백질의 변성과 대상 물질에 동일하게 조사를 할 수 있는 기계적 장치 개발의 어려움으로 인해 UVC 조사는 생물의약품 제조 공정에 사용되지 못했다. 최근에 이러한 결점을 해결한 연속 유동 UVC 반응기(UVivatec)가 개발되었다. UVivatec의 바이러스 불활화 효과 및 단백질 회수율을 검증하기 위해 단백질 의약품을 대상으로 적용가능성을 조사하였다. 최적화된 $3,000\;J/m^2$ 조사 공정에서 단백질의 회수율은 98%이상이었다. UVC 조사에 의한 human immunodeficiency virus(HIV), hepatitis A virus(HAV), bovine herpes virus(BHV), bovine viral diarrhea virus(BVDV), porcine parvovirus(PPV), bovine parvovirus(BPV), minute virus of mice(MVM), reovirus type 3(REO), bovine parainfluenza virus type 3(BPIV) 불활화 효과를 평가하였다. HAV, PPV, BPV, MVM, REO와 같은 비외피(nonenvelope) 바이러스는 $3,000\;J/m^2$ 조사량에 의해 검출한계 이하로 완벽하게 불활화되었다. HIV, BVDV, BPIV 같은 외피(envelope) 바이러스도 $3,000\;J/m^2$ 조사량에 의해 검출한계 이하로 완벽하게 불활화되었다. 또한 BHV도 매우 민감하게 불활화되었다. UVC 조사에 의한 각 바이러스들의 로그 감소율은 HIV는 ${\geq}3.89$, HAV는 ${\geq}5.27$, BHV는 5.29, BVDV는 ${\geq}5.96$, PPV는 ${\geq}4.37$, BPV는 ${\geq}3.55$, MVM은 ${\geq}3.51$, REO는 ${\geq}4.20$, BPIV는 ${\geq}4.15$이었다. 이와 같은 결과에서 UVivatec을 이용한 UVC 조사는 바이러스 불활화에 매우 효과적인 방법임을 확인하였다.

Research status for long term half-life PET radioisotopes in KIRAMS

  • Kim, Jung Young;Park, Hyun;Chun, Kwon Soo;An, Gwang Il
    • 대한방사성의약품학회지
    • /
    • 제1권1호
    • /
    • pp.1-8
    • /
    • 2015
  • It is essential use of long term half life radioisotopes for positron emission tomography (PET) imaging study of biopharmaceuticals because most of biopharmaceuticals have long biological half-life. Some representative isotopes are $^{124}I$, $^{64}Cu$, $^{89}Zr$ and so on. These PET radioisotopes and their radiopharmaceuticals have recently received growing interest because of long half life and good imaging properties. Furthermore, $^{64}Cu$ and $^{89}Zr$ can be used in a number of radiopharmaceuticals due to its ease of conjugation to peptides and antibodies using the proper chelator. In recent years, since $^{124}I$ was first developed in 2005, we have been studied to develop an efficient method and procedure for producing these radioisotopes, and we have made considerable progress in production of long term half life radioisotopes. This review introduces the general production system, purification procedure, and several advances on targeting method for $^{124}I$ and $^{64}Cu$ in KIRAMS.